ERC Consolidator Grant · 2021
Deciphering the Exposome by Metabolomic Technology in Breast Cancer
EXPOMET proposes a pioneering mass spectrometry-based platform for omic-scale assessment of chemical exposures. EXPOMET will revolutionize our perception of environmental contaminants and the influence these have on breast cancer (BC). In our ageing society, the incidence of chronic disease is constantly rising; yet, environmental drivers of disease susceptibility are poorly understood. Measuring the myriad of chemicals that humans are constantly exposed to is immensely challenging; and identifying interactions and the molecular pathways that are disrupted is an even more complex task. To address this issue, the concept of the exposome, i.e., the totality of chemical exposures and the…
From the public funding record at EU CORDIS. Describes the funded project, not the reviews below.